Pear Therapeutics receives FDA breakthrough device designation for prescription digital therapeutic candidate to treat alcohol use disorder

22 November 2021 – Pear Therapeutics today announced that it has received breakthrough device designation from the U.S. FDA for ...

Read more →

Luminopia announces FDA approval of digital therapeutic that uses TV shows to improve vision in children with lazy eye

20 October 2021 - Luminopia One improves vision in children with amblyopia, the leading cause of vision loss in children, and ...

Read more →

Pear Therapeutics launches Pear Prescription Digital Therapeutics Digest, provides roadmap for payer coverage considerations

19 October 2021 - Pear Therapeutics, in collaboration with Avalere Health, today launched the Pear Prescription Digital Therapeutics Digest at ...

Read more →

Scotland is first country to offer free digital therapies to every adult

13 October 2021 - The Scottish Government has announced that all Scottish adults will now have access to "digital therapeutics" ...

Read more →

Prime Therapeutics and Pear Therapeutics announce first comprehensive value based agreement for prescription digital therapeutics reSET and reSET-O for the treatment of substance and opioid use disorders

29 September 2021 - Agreement aims to reduce inpatient hospitalisations and total cost of care. ...

Read more →

Pear Therapeutics announces additional coverage decisions and formulary adoption of its prescription digital therapeutics

23 September 2021 - More than 30 organizations now provide access to Pear’s prescription digital therapeutics by either listing on formulary, ...

Read more →

FDA grants breakthrough device designation for ImpediMed's SOZO digital health platform for renal failure

30 August 2021 - FDA recognises potential of SOZO digital health platform to assist clinicians in measuring exact fluid volume of ...

Read more →

Swing Therapeutics receives FDA breakthrough device designation for digital therapeutic for the management of fibromyalgia, launches real world study

11 August 2021 - Approach based on acceptance and commitment therapy and a foundational clinically validated digital program licensed from University ...

Read more →

Pear Therapeutics announces formulary availability for its three FDA authorised prescription digital therapeutics at OptumRx

10 August 2021 - OptumRx to make Pear’s three commercial prescription digital therapeutics accessible to patients with Optum formulary access. ...

Read more →

Abbott receives FDA clearance for its imaging technology using artificial intelligence for vessels in the heart

3 August 2021 - Ultreon 1.0 software, the first-of-its-kind imaging software, merges optical coherence tomography with the power of automation using ...

Read more →

Regulating digital health apps needs user-centered reform

3 August 2021 - When people seek health information, they expect what they get to be reliable and accurate.  ...

Read more →

HumanFirst joins the FDA, HHS and more than 20 organisations and leading health companies to launch the Digital Health Measurement Collaborative Community

3 June 2021 - Digital Health Measurement Experts will work together to develop best practices and streamline health measurement using digital ...

Read more →

Roche launches mySugr Pump Control within the mySugr app to simplify insulin pump therapy via smartphone

19 May 2021 - mySugr now allows control of the Accu-Chek Insight insulin pump directly via smartphone, starting in Austria, bringing ...

Read more →

Modernising Medicare coverage pathways for prescription digital therapeutics

13 May 2021 - Outpatient visit restrictions imposed in early 2020 due to COVID-19 increased demand for effective virtual health care ...

Read more →

NICE’s Office for Digital Health opens its doors

11 May 2021 - UK cost effectiveness agency NICE has this week officially opened the Office for Digital Health, one ...

Read more →